Total Payments
$20,129
2024 Payments
$3,011
Companies
59
Transactions
668
Medicare Patients
3,941
Medicare Billing
$485,021
Payment Breakdown by Category
Food & Beverage$14,581 (72.4%)
Consulting$4,950 (24.6%)
Travel$350.51 (1.7%)
Education$248.45 (1.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,581 | 656 | 72.4% |
| Consulting Fee | $4,950 | 1 | 24.6% |
| Travel and Lodging | $350.51 | 2 | 1.7% |
| Education | $248.45 | 9 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Insmed, Inc. | $6,346 | 42 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,413 | 101 | $0 (2024) |
| GlaxoSmithKline, LLC. | $2,105 | 115 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,030 | 75 | $0 (2024) |
| Allergan, Inc. | $599.35 | 16 | $0 (2020) |
| Merck Sharp & Dohme LLC | $526.12 | 17 | $0 (2024) |
| GENZYME CORPORATION | $351.13 | 12 | $0 (2024) |
| Mylan Specialty L.P. | $339.47 | 18 | $0 (2024) |
| Novo Nordisk Inc | $322.53 | 20 | $0 (2024) |
| Genentech USA, Inc. | $312.28 | 25 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,011 | 115 | GlaxoSmithKline, LLC. ($445.40) |
| 2023 | $3,006 | 121 | Boehringer Ingelheim Pharmaceuticals, Inc. ($614.54) |
| 2022 | $1,037 | 51 | Boehringer Ingelheim Pharmaceuticals, Inc. ($192.85) |
| 2021 | $1,035 | 48 | Boehringer Ingelheim Pharmaceuticals, Inc. ($299.95) |
| 2020 | $1,241 | 69 | GlaxoSmithKline, LLC. ($210.66) |
| 2019 | $7,514 | 125 | Insmed, Inc. ($5,538) |
| 2018 | $1,919 | 87 | AstraZeneca Pharmaceuticals LP ($488.18) |
| 2017 | $1,366 | 52 | GlaxoSmithKline, LLC. ($392.95) |
All Payment Transactions
668 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $31.51 | General |
| Category: Diabetes | ||||||
| 12/12/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $119.94 | General |
| Category: RESPIRATORY | ||||||
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: RESPIRATORY | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: Respiratory | ||||||
| 11/26/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: ANTIBIOTIC | ||||||
| 11/25/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $29.16 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $37.22 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/20/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $41.13 | General |
| Category: HFCWO | ||||||
| 11/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $126.86 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: RESPIRATORY | ||||||
| 11/18/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: UROLOGY | ||||||
| 11/07/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $25.31 | General |
| Category: Respiratory | ||||||
| 11/05/2024 | Vifor Pharma, Inc. | Zemaira (Drug) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 11/01/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/31/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: RESPIRATORY | ||||||
| 10/29/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $118.97 | General |
| Category: Immunology | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $42.38 | General |
| Category: Immunology | ||||||
| 10/21/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $29.41 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Pulmonology | ||||||
| 10/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,053 | 1,813 | $323,944 | $132,650 |
| 2022 | 10 | 855 | 1,347 | $243,227 | $96,340 |
| 2021 | 11 | 1,031 | 1,942 | $327,129 | $132,357 |
| 2020 | 12 | 1,002 | 2,140 | $333,422 | $123,675 |
Total Patients
3,941
Total Services
7,242
Medicare Billing
$485,021
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 248 | 426 | $102,240 | $44,990 | 44.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 223 | 309 | $50,367 | $22,242 | 44.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 72 | 402 | $34,170 | $16,784 | 49.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 94 | 94 | $34,122 | $13,209 | 38.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 84 | 175 | $27,650 | $11,684 | 42.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 85 | 105 | $31,080 | $11,564 | 37.2% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 182 | 232 | $19,488 | $5,225 | 26.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 47 | 47 | $11,280 | $4,175 | 37.0% |
| 31645 | Aspiration of initial secretion of lung airway using an endoscope | Facility | 2023 | 18 | 23 | $13,547 | $2,777 | 20.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 167 | 265 | $63,600 | $28,685 | 45.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 258 | 356 | $58,028 | $25,063 | 43.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 65 | 65 | $23,595 | $8,806 | 37.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 57 | 69 | $20,424 | $8,010 | 39.2% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 48 | 235 | $19,975 | $7,850 | 39.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 49 | 107 | $16,906 | $6,602 | 39.1% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 143 | 176 | $14,784 | $3,923 | 26.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 39 | 39 | $9,360 | $3,405 | 36.4% |
| 31645 | Aspiration of initial secretion of lung airway using an endoscope | Facility | 2022 | 15 | 21 | $12,369 | $2,620 | 21.2% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2022 | 14 | 14 | $4,186 | $1,376 | 32.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 278 | 430 | $70,090 | $31,851 | 45.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 137 | 204 | $48,960 | $22,976 | 46.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 107 | 125 | $37,000 | $14,731 | 39.8% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 12 | 239 | $36,328 | $13,856 | 38.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 100 | 217 | $34,286 | $13,493 | 39.4% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 93 | 389 | $33,065 | $12,866 | 38.9% |
About Dr. Jack Stewart, M.D
Dr. Jack Stewart, M.D is a Pulmonary Disease healthcare provider based in Orange, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1942278452.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jack Stewart, M.D has received a total of $20,129 in payments from pharmaceutical and medical device companies, with $3,011 received in 2024. These payments were reported across 668 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($14,581).
As a Medicare-enrolled provider, Stewart has provided services to 3,941 Medicare beneficiaries, totaling 7,242 services with total Medicare billing of $485,021. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Orange, CA
- Active Since 03/09/2006
- Last Updated 07/21/2022
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1942278452
Products in Payments
- Arikayce (Drug) $6,346
- OFEV (Drug) $803.82
- TRELEGY ELLIPTA (Drug) $647.27
- DUPIXENT (Biological) $565.23
- AVYCAZ (Drug) $530.83
- STIOLTO RESPIMAT (Drug) $452.34
- NUCALA (Biological) $382.17
- IMFINZI (Drug) $376.38
- ELIQUIS (Drug) $338.74
- BREZTRI (Drug) $327.94
- TEZSPIRE (Biological) $300.59
- BREO (Drug) $297.11
- FASENRA (Biological) $285.69
- BEVESPI AEROSPHERE (Drug) $284.93
- TYVASO (Drug) $257.59
- JARDIANCE (Drug) $247.13
- WINREVAIR (Biological) $232.04
- XARELTO (Drug) $224.77
- YUPELRI (Drug) $223.75
- Xolair (Biological) $218.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Orange
Bassam Yaghmour, M.d, M.D
Pulmonary Disease — Payments: $317,412
Pulmonary Disease $317,412
Dr. James Pearle, M.d, M.D
Pulmonary Disease — Payments: $133,562
Pulmonary Disease $133,562
Dr. Jasdeep Sidana, Md, MD
Pulmonary Disease — Payments: $40,012
Pulmonary Disease $40,012
Dr. Asad Javed, Medical Doctor, MEDICAL DOCTOR
Pulmonary Disease — Payments: $23,900
Pulmonary Disease $23,900
Raymond Casciari, M.d, M.D
Pulmonary Disease — Payments: $17,121
Pulmonary Disease $17,121
Matthew Brenner, Md, MD
Pulmonary Disease — Payments: $16,169
Pulmonary Disease $16,169